JP2013526501A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013526501A5 JP2013526501A5 JP2013509525A JP2013509525A JP2013526501A5 JP 2013526501 A5 JP2013526501 A5 JP 2013526501A5 JP 2013509525 A JP2013509525 A JP 2013509525A JP 2013509525 A JP2013509525 A JP 2013509525A JP 2013526501 A5 JP2013526501 A5 JP 2013526501A5
- Authority
- JP
- Japan
- Prior art keywords
- cooh
- insulin
- chain
- group
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10162368 | 2010-05-10 | ||
| EP10162368.4 | 2010-05-10 | ||
| US33349710P | 2010-05-11 | 2010-05-11 | |
| US61/333,497 | 2010-05-11 | ||
| PCT/EP2011/057388 WO2011141407A1 (en) | 2010-05-10 | 2011-05-09 | Process for the preparation of insulin-zinc complexes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017157054A Division JP2017203042A (ja) | 2010-05-10 | 2017-08-16 | インスリン−亜鉛錯体の調製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013526501A JP2013526501A (ja) | 2013-06-24 |
| JP2013526501A5 true JP2013526501A5 (https=) | 2014-05-08 |
| JP6249773B2 JP6249773B2 (ja) | 2017-12-20 |
Family
ID=42732779
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013509525A Active JP6249773B2 (ja) | 2010-05-10 | 2011-05-09 | インスリン−亜鉛錯体の調製方法 |
| JP2017157054A Withdrawn JP2017203042A (ja) | 2010-05-10 | 2017-08-16 | インスリン−亜鉛錯体の調製方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017157054A Withdrawn JP2017203042A (ja) | 2010-05-10 | 2017-08-16 | インスリン−亜鉛錯体の調製方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US20130143803A1 (https=) |
| EP (1) | EP2569002B1 (https=) |
| JP (2) | JP6249773B2 (https=) |
| KR (2) | KR20160105979A (https=) |
| CN (2) | CN102883743A (https=) |
| AU (1) | AU2011252127B2 (https=) |
| BR (1) | BR112012028766A2 (https=) |
| CA (1) | CA2795091A1 (https=) |
| ES (1) | ES2612468T3 (https=) |
| MX (1) | MX2012012943A (https=) |
| RU (1) | RU2572214C2 (https=) |
| WO (1) | WO2011141407A1 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006082204A1 (en) | 2005-02-02 | 2006-08-10 | Novo Nordisk A/S | Insulin derivatives |
| JP4808785B2 (ja) | 2005-12-28 | 2011-11-02 | ノボ・ノルデイスク・エー／エス | インスリン組成物および組成物の製造方法 |
| EP1991576B1 (en) | 2006-02-27 | 2010-09-29 | Novo Nordisk A/S | Insulin derivatives |
| EP2024390B1 (en) | 2006-05-09 | 2015-08-19 | Novo Nordisk A/S | Insulin derivative |
| MX2008014061A (es) | 2006-05-09 | 2008-11-14 | Novo Nordisk As | Derivado de insulina. |
| US9034818B2 (en) | 2007-06-13 | 2015-05-19 | Novo Nordisk A/S | Pharmaceutical formulations comprising an insulin derivative |
| US8710000B2 (en) | 2007-11-08 | 2014-04-29 | Novo Nordisk A/S | Insulin derivative |
| AU2009309623B9 (en) | 2008-10-30 | 2014-10-02 | Novo Nordisk A/S | Treating diabetes melitus using insulin injections with less than daily injection frequency |
| DK2632478T3 (da) | 2010-10-27 | 2019-10-07 | Novo Nordisk As | Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller |
| JP6755175B2 (ja) * | 2013-03-20 | 2020-09-16 | ノヴォ ノルディスク アー／エス | インスリン投薬レジメン |
| JP2016519127A (ja) | 2013-04-30 | 2016-06-30 | ノヴォ ノルディスク アー／エス | 新規投与レジメン |
| AU2014333979B2 (en) * | 2013-10-07 | 2018-02-15 | Novo Nordisk A/S | Novel derivative of an insulin analogue |
| AR099569A1 (es) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
| DK3006045T3 (en) | 2014-10-07 | 2017-07-17 | Cyprumed Gmbh | Pharmaceutical formulations for oral administration of peptide or protein drugs |
| WO2019110797A1 (fr) * | 2017-12-07 | 2019-06-13 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
| WO2019110788A1 (fr) | 2017-12-07 | 2019-06-13 | Adocia | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide |
| CN111315766B (zh) * | 2018-02-01 | 2023-05-12 | 江苏恒瑞医药股份有限公司 | 含人胰岛素类似物的酰化衍生物的药物组合物及其制备方法 |
| KR20210016400A (ko) | 2018-05-24 | 2021-02-15 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 재조합 인간 인슐린 또는 그 유사체의 전구체를 제조하는 방법 |
| US10335464B1 (en) | 2018-06-26 | 2019-07-02 | Novo Nordisk A/S | Device for titrating basal insulin |
| SG11202106167XA (en) | 2018-12-11 | 2021-07-29 | Sanofi Sa | Insulin conjugates |
| US12343383B2 (en) | 2019-07-12 | 2025-07-01 | Novo Nordisk A/S | High concentration insulin formulation |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1212679B (de) * | 1957-08-03 | 1966-03-17 | Novo Terapeutisk Labor As | Verfahren zur Herstellung von Insulinloesungen |
| GB1042194A (en) * | 1962-04-30 | 1966-09-14 | Olin Mathieson | Insulin preparations |
| US3868358A (en) * | 1971-04-30 | 1975-02-25 | Lilly Co Eli | Protamine-insulin product |
| DK113585D0 (da) * | 1985-03-12 | 1985-03-12 | Novo Industri As | Nye peptider |
| PH25772A (en) * | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| US4764592A (en) * | 1987-04-23 | 1988-08-16 | Eli Lilly And Company | Crystalline human proinsulin and process for its production |
| KR910700262A (ko) | 1988-12-23 | 1991-03-14 | 안네 제케르 | 사람 인슐린 유사체 |
| PT93057B (pt) | 1989-02-09 | 1995-12-29 | Lilly Co Eli | Processo para a preparacao de analogos da insulina |
| CZ287945B6 (cs) * | 1993-09-17 | 2001-03-14 | Novo Nordisk A/S | Inzulinový derivát a farmaceutický prostředek s jeho obsahem pro léčení diabetu |
| US7097845B2 (en) * | 1997-04-23 | 2006-08-29 | Jacob Sten Petersen | Combinations of antigen and mucosal binding component for inducing specific immunological tolerance |
| MXPA06001283A (es) | 2003-08-05 | 2006-04-11 | Novo Nordisk As | Derivados de insulina novedosos. |
| SI2107069T1 (sl) * | 2003-08-05 | 2013-04-30 | Novo Nordisk A/S | Novi inzulinski derivati |
| JP4808785B2 (ja) * | 2005-12-28 | 2011-11-02 | ノボ・ノルデイスク・エー／エス | インスリン組成物および組成物の製造方法 |
| US9034818B2 (en) * | 2007-06-13 | 2015-05-19 | Novo Nordisk A/S | Pharmaceutical formulations comprising an insulin derivative |
| TWI451876B (zh) * | 2008-06-13 | 2014-09-11 | Lilly Co Eli | 聚乙二醇化之離脯胰島素化合物 |
-
2011
- 2011-05-09 US US13/696,897 patent/US20130143803A1/en not_active Abandoned
- 2011-05-09 CN CN201180023303XA patent/CN102883743A/zh active Pending
- 2011-05-09 AU AU2011252127A patent/AU2011252127B2/en not_active Ceased
- 2011-05-09 WO PCT/EP2011/057388 patent/WO2011141407A1/en not_active Ceased
- 2011-05-09 KR KR1020167023293A patent/KR20160105979A/ko not_active Ceased
- 2011-05-09 CN CN201611166272.4A patent/CN107029212A/zh active Pending
- 2011-05-09 JP JP2013509525A patent/JP6249773B2/ja active Active
- 2011-05-09 CA CA2795091A patent/CA2795091A1/en not_active Withdrawn
- 2011-05-09 ES ES11718398.8T patent/ES2612468T3/es active Active
- 2011-05-09 KR KR1020127029547A patent/KR20130092972A/ko not_active Ceased
- 2011-05-09 BR BR112012028766A patent/BR112012028766A2/pt not_active Application Discontinuation
- 2011-05-09 MX MX2012012943A patent/MX2012012943A/es active IP Right Grant
- 2011-05-09 EP EP11718398.8A patent/EP2569002B1/en active Active
- 2011-05-09 RU RU2012148821/15A patent/RU2572214C2/ru not_active IP Right Cessation
-
2015
- 2015-03-19 US US14/662,874 patent/US20150250857A1/en not_active Abandoned
-
2017
- 2017-02-28 US US15/445,305 patent/US20170165327A1/en not_active Abandoned
- 2017-08-16 JP JP2017157054A patent/JP2017203042A/ja not_active Withdrawn
-
2020
- 2020-08-12 US US16/991,803 patent/US20210060132A1/en not_active Abandoned
-
2024
- 2024-05-24 US US18/674,042 patent/US20240307503A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013526501A5 (https=) | ||
| JP2011006428A5 (https=) | ||
| RU2012148821A (ru) | Способ получения цинковых комплексов инсулина | |
| US10004704B2 (en) | Compositions and methods for treating chronic inflammation and inflammatory diseases | |
| CA2846598C (en) | Treatment of degenerative joint disease | |
| JP2014520798A5 (https=) | ||
| EP3494961A1 (en) | Compositions and methods for treating chronic inflammation and inflammatory diseases | |
| RU2015100901A (ru) | Производные эфира гетероарилкарбоновой кислоты | |
| JP2013523896A5 (https=) | ||
| WO2012165915A3 (en) | Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugate | |
| CA3084688A1 (fr) | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide porteur de charges carboxylates et de radicaux hydrophobes | |
| TW200418906A (en) | High-molecular weight derivatives of camptothecins | |
| TW200914460A (en) | Proteasome inhibitors | |
| WO2013104861A1 (fr) | Solution injectable a ph 7 comprenant au moins une insuline basale dont le pi est compris entre 5,8 et 8,5 et un co-polyaminoacide substitue | |
| JP2011516428A5 (https=) | ||
| AU2007274402A1 (en) | Polymer conjugate of combretastatin | |
| WO2011015634A3 (en) | Controlled release formulations of lipocalin muteins | |
| WO2011018635A3 (en) | Photosensitizing compositions | |
| RU2014109441A (ru) | Амидные соединения, способы получения, применение в качестве средств для лечения и профилактики заболеваний, вызываемых рнк-содержащими вирусами | |
| JP2023540149A (ja) | 抗ウイルス化合物の製剤 | |
| WO2006131923A3 (en) | Novel salts of conjugated psychotropic drugs and processes of preparing same | |
| CA2565993A1 (en) | Salt of 4-or 5- aminosalicylic acid | |
| WO2020025825A1 (fr) | Solution injectable a ph 7 comprenant du glucagon humain, au moins une espece ionique et un compose amphiphile porteur de radicaux hydrophobes | |
| FR3084586A1 (fr) | Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un compose amphiphile porteur de radicaux hydrophobes | |
| WO2012165916A3 (en) | Non-peptidyl polymer-insulin multimer and method for producing the same |